Reply to "Lack of Evidence for Reduced Fitness of Clinical Staphylococcus Aureus Isolates With Reduced Susceptibility to Triclosan"

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01515-12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Genetic Changes That Correlate With Reduced Susceptibility to Daptomycin in Staphylococcus Aureus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Rapid Detection of Staphylococcus Aureus Strains With Reduced Susceptibility to Vancomycin by Isothermal Microcalorimetry

Journal of Clinical Microbiology
Microbiology
2013English

First Report of Methicillin-Resistant Staphylococcus Aureus With Reduced Susceptibility to Vancomycin in Thailand

Journal of Clinical Microbiology
Microbiology
2001English

Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus Aureus Clinical Isolates in Northeast China

PLoS ONE
Multidisciplinary
2013English

Clonal Spread of Staphylococcus Aureus With Reduced Susceptibility to Oxacillin in a Dermatological Hospital Unit

Acta Dermato-Venereologica
DermatologyMedicine
2006English

Endocarditis Caused by Methicillin-Susceptible Staphylococcus Aureus With Reduced Susceptibility to Vancomycin: A Case Report

Journal of Medical Case Reports
Medicine
2011English

Activity of AZD2563, a Novel Oxazolidinone, Against Staphylococcus Aureus Strains With Reduced Susceptibility to Vancomycin or Linezolid

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2003English

IS256-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a Staphylococcus Aureus Clinical Isolate

Frontiers in Microbiology
Microbiology
2019English

Comparison of Human and Soil Candida Tropicalis Isolates With Reduced Susceptibility to Fluconazole

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy